GCC And UAE Diabetes Devices Market Size, Share & Trends Report

GCC And UAE Diabetes Devices Market Size, Share & Trends Analysis Report By Services (Devices And Wearables, Diabetes Prevention, Diabetes Researches), By Distribution Channel, By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • Report ID: GVR-4-68040-019-0
  • Number of Pages: 100
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2021
  • Industry: Healthcare

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation & Scope
                       1.1.1. Services
                       1.1.2. Distribution Channel
                       1.1.3. End-use
                       1.1.4. Estimates and forecast timeline
                   1.2. Research Methodology
                   1.3. Information Procurement
                       1.3.1. Purchased database
                       1.3.2. GVR’s internal database
                       1.3.3. Secondary sources
                       1.3.4. Primary research
                   1.4. Information or Data Analysis
                       1.4.1. Data analysis models
                   1.5. Market Formulation & Validation
                   1.6. Model Details
                       1.6.1. Commodity flow analysis (Model 1)
                           1.6.1.1. Approach 1: Commodity flow approach
                       1.6.2. Volume price analysis (Model 2)
                           1.6.2.1. Approach 2: Volume price analysis
                   1.7. List of Secondary Sources
                   1.8. List of Primary Sources
                   1.9. Objectives
                       1.9.1. Objective 1: Understanding the market dynamics
                       1.9.2. Objective 2: Understanding the market estimates and forecasts
                       1.9.3. Objective 3: Understanding the attributes such as strategy framework, competitor categorization
                       1.9.4. Objective 4: Understanding the key product and application scopes to conclude on the market size
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                   2.3. Competitive Insights
Chapter 3. GCC and UAE Diabetes Devices Market Variables, Trends & Scope
                   3.1. Market Lineage outlook
                       3.1.1. Parent market outlook
                       3.1.2. Related/ancillary market outlook
                   3.2. Penetration & Growth Prospect Mapping
                   3.3. Product Pipeline Analysis, by Stage
                   3.4. Market Dynamics
                       3.4.1. Market Driver Analysis
                           3.4.1.1. Easy and efficient monitoring of blood glucose levels
                           3.4.1.2. Technological advancements
                           3.4.1.3. Increasing awareness about diabetes preventive care
                       3.4.2. Market Restraint Analysis
                           3.4.2.1. High cost of devices
                   3.5. GCC and UAE Diabetes Devices: Market Analysis Tools
                       3.5.1. Industry Analysis - Porter’s
                           3.5.1.1. Supplier Power
                           3.5.1.2. Buyer Power
                           3.5.1.3. Substitution Threat
                           3.5.1.4. Threat from new entrant
                           3.5.1.5. Competitive rivalry
                       3.5.2. PESTEL Analysis
                           3.5.2.1. Political Landscape
                           3.5.2.2. Environmental Landscape
                           3.5.2.3. Social Landscape
                           3.5.2.4. Technology Landscape
                           3.5.2.5. Legal Landscape
                       3.5.3. Major Deals & Strategic Alliances Analysis
                       3.5.4. Covid-19 Impact Analysis
Chapter 4. GCC and UAE Diabetes Devices Market: Segment Analysis, by Services, 2018 - 2030 (USD Million)
                   4.1. Definitions & Scope
                   4.2. Services market share analysis, 2022 & 2030
                   4.3. Segment Dashboard
                   4.4. GCC and UAE Diabetes Devices Market, by Services, 2018 to 2030
                   4.5. Market Size & Forecasts and Trend Analysis, 2018 to 2030 for the following
                       4.5.1. Devices and Wearables
                           4.5.1.1. Devices and wearables estimates and forecast, 2018 to 2030 (USD Million)
                       4.5.2. Pharma, drugs and supplies
                           4.5.2.1. Pharma, drugs and supplies estimates and forecast, 2018 to 2030 (USD Million)
                       4.5.3. Technology platforms and products
                           4.5.3.1. Technology platforms and products estimates and forecast, 2018 to 2030 (USD Million)
                       4.5.4. Genomics and multi-omics
                           4.5.4.1. Genomics and multi-omics estimates and forecast, 2018 to 2030 (USD Million)
                       4.5.5. Diabetes prevention
                           4.5.5.1. Diabetes prevention estimates and forecast, 2018 to 2030 (USD Million)
                       4.5.6. Diabetes research
                           4.5.6.1. Diabetes researches estimates and forecast, 2018 to 2030 (USD Million)
                       4.5.7. Primary care
                           4.5.7.1. Primary care estimates and forecast, 2018 to 2030 (USD Million)
Chapter 5. GCC and UAE Diabetes Devices Market: Segment Analysis, By Distribution Channel, 2018 - 2030 (USD Million)
                   5.1. Definitions & Scope
                   5.2. Distribution channel market share analysis, 2022 & 2030
                   5.3. Segment Dashboard
                   5.4. GCC and UAE Diabetes Devices Market, By distribution channel, 2018 to 2030
                   5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                       5.5.1. Hospital pharmacies
                           5.5.1.1. Hospital pharmacies estimates and forecast, 2018 to 2030 (USD Million)
                       5.5.2. Retail pharmacies
                           5.5.2.1. Retail pharmacies estimates and forecast, 2018 to 2030 (USD Million)
                       5.5.3. Diabetes clinics/centers
                           5.5.3.1. Diabetes clinics/centers estimates and forecast, 2018 to 2030 (USD Million)
                       5.5.4. Online pharmacies
                           5.5.4.1. Online pharmacies estimates and forecast, 2018 to 2030 (USD Million)
                       5.5.5. Others
                           5.5.5.1. Others estimates and forecast, 2018 to 2030 (USD Million)
Chapter 6. GCC and UAE Diabetes Devices Market: Segment Analysis, By End-use, 2018 - 2030 (USD Million)
                   6.1. Definitions & Scope
                   6.2. End-use market share analysis, 2022 & 2030
                   6.3. Segment Dashboard
                   6.4. GCC and UAE Diabetes Devices Market, By End-use, 2018 to 2030
                   6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                       6.5.1. Hospitals
                           6.5.1.1. Hospitals estimates and forecast, 2018 to 2030 (USD Million)
                       6.5.2. Homecare
                           6.5.2.1. Homecare estimates and forecast, 2018 to 2030 (USD Million)
                       6.5.3. Diagnostic centers
                           6.5.3.1. Diagnostic centers estimate and forecast, 2018 to 2030 (USD Million)
Chapter 7. GCC and UAE Diabetes Devices Market: Regional Market Analysis, 2018 - 2030 (USD Million)
                   7.1. Definitions & Scope
                   7.2. Regional Market Share Analysis, 2022 & 2030
                   7.3. Regional Market Dashboard
                   7.4. Regional Market Snapshot
                   7.5. Regional Market Share, 2022
                   7.6. Market Size, & Forecasts, and Trend Analysis, 2018 to 2030
                   7.7. Saudi Arabia
                       7.7.1. Market estimates and forecast, by services, 2018 - 2030 (USD Million)
                       7.7.2. Market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
                       7.7.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
                   7.8. UAE
                       7.8.1. Market estimates and forecast, by services, 2018 - 2030 (USD Million)
                       7.8.2. Market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
                       7.8.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
                   7.9. Oman
                       7.9.1. Market estimates and forecast, by services, 2018 - 2030 (USD Million)
                       7.9.2. Market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
                       7.9.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
                   7.10. Qatar
                       7.10.1. Market estimates and forecast, by services, 2018 - 2030 (USD Million)
                       7.10.2. Market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
                       7.10.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
                   7.11. Kuwait
                       7.11.1. Market estimates and forecast, by services, 2018 - 2030 (USD Million)
                       7.11.2. Market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
                       7.11.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
                   7.12. Bahrain
                       7.12.1. Market estimates and forecast, by services, 2018 - 2030 (USD Million)
                       7.12.2. Market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
                       7.12.3. Market estimates and forecast, by end-use, 2018 - 2030 (USD Million)
Chapter 8. GCC and UAE Diabetes Devices Market - Competitive Analysis
                   8.1. Key companies profiled
                       8.1.1. Medtronic
                           8.1.1.1. Company Overview
                           8.1.1.2. Financial Performance
                           8.1.1.3. Product Benchmarking
                           8.1.1.4. Strategic Initiatives
                       8.1.2. Abbot Laboratories
                           8.1.2.1. Company Overview
                           8.1.2.2. Financial Performance
                           8.1.2.3. Product Benchmarking
                           8.1.2.4. Strategic Initiatives
                       8.1.3. Ascensia Diabetes Care Holdings
                           8.1.3.1. Company Overview
                           8.1.3.2. Financial Performance
                           8.1.3.3. Product Benchmarking
                           8.1.3.4. Strategic Initiatives
                       8.1.4. Dexcom
                           8.1.4.1. Company Overview
                           8.1.4.2. Financial Performance
                           8.1.4.3. Product Benchmarking
                           8.1.4.4. Strategic Initiatives
                       8.1.5. F. Hoffmann- La Roche AG
                           8.1.5.1. Company Overview
                           8.1.5.2. Financial Performance
                           8.1.5.3. Product Benchmarking
                           8.1.5.4. Strategic Initiatives
                       8.1.6. Sanofi
                           8.1.6.1. Company Overview
                           8.1.6.2. Financial Performance
                           8.1.6.3. Product Benchmarking
                           8.1.6.4. Strategic Initiatives
                       8.1.7. Novo Nordisk A/S
                           8.1.7.1. Company Overview
                           8.1.7.2. Financial Performance
                           8.1.7.3. Product Benchmarking
                           8.1.7.4. Strategic Initiatives
                       8.1.8. Insulet Corporation
                           8.1.8.1. Company Overview
                           8.1.8.2. Financial Performance
                           8.1.8.3. Product Benchmarking
                           8.1.8.4. Strategic Initiatives
                       8.1.9. Ypsomed AG
                           8.1.9.1. Company Overview
                           8.1.9.2. Financial Performance
                           8.1.9.3. Product Benchmarking
                           8.1.9.4. Strategic Initiatives
                       8.1.10. Eli Lily
                           8.1.10.1. Company Overview
                           8.1.10.2. Financial Performance
                           8.1.10.3. Product Benchmarking
                           8.1.10.4. Strategic Initiatives
                       8.1.11. Astra Zeneca
                           8.1.11.1. Company Overview
                           8.1.11.2. Financial Performance
                           8.1.11.3. Product Benchmarking
                           8.1.11.4. Strategic Initiatives


List of Tables

Table 1 List of Abbreviations
Table 2 GCC and UAE diabetes devices market, by services, 2018 - 2030 (USD Million)
Table 3 GCC and UAE diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 4 GCC and UAE diabetes devices market, by end-use, 2018 - 2030 (USD Million)
Table 5 Saudi Arabia diabetes devices market, by services, 2018 - 2030 (USD Million)
Table 6 Saudi Arabia diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 7 Saudi Arabia diabetes devices market, by end-use, 2018 - 2030 (USD Million)
Table 8 UAE diabetes devices market, by services, 2018 - 2030 (USD Million)
Table 9 UAE diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 10 UAE diabetes devices market, by end-use, 2018 - 2030 (USD Million)
Table 11 Oman diabetes devices market, by services, 2018 - 2030 (USD Million)
Table 12 Oman diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 13 Oman diabetes devices market, by end-use, 2018 - 2030 (USD Million)
Table 14 Qatar diabetes devices market, by services, 2018 - 2030 (USD Million)
Table 15 Qatar diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 16 Qatar diabetes devices market, by end-use, 2018 - 2030 (USD Million)
Table 17 Kuwait diabetes devices market, by services, 2018 - 2030 (USD Million)
Table 18 Kuwait diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 19 Kuwait diabetes devices market, by end-use, 2018 - 2030 (USD Million)
Table 20 Bahrain diabetes devices market, by services, 2018 - 2030 (USD Million)
Table 21 Bahrain diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 22 Bahrain diabetes devices market, by end-use, 2018 - 2030 (USD Million)


List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 GCC and UAE diabetes devices market: Market snapshot
Fig. 9 GCC and UAE diabetes devices market: Market segmentation
Fig. 10 GCC and UAE diabetes devices market Strategy framework
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 GCC and UAE diabetes devices market driver impact
Fig. 14 GCC and UAE diabetes devices market restraint impact
Fig. 15 GCC and UAE diabetes devices market porter’s five forces analysis
Fig. 16 GCC and UAE diabetes devices market PESTEL analysis
Fig. 17 GCC and UAE diabetes devices market segment dashboard
Fig. 18 GCC and UAE diabetes devices market: services movement analysis
Fig. 19 Devices and Wearables market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Pharma, drugs and supplies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Technology platforms and products market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Genomics and multi-omics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Diabetes prevention market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Diabetes researches market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Primary care market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 GCC and UAE diabetes devices market: Segment dashboard
Fig. 27 GCC and UAE diabetes devices market: Distribution channel movement analysis
Fig. 28 Hospital pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Retail pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Diabetes clinics centers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Online pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Others pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 GCC and UAE diabetes devices market segment dashboard
Fig. 34 GCC and UAE diabetes devices market: End-use movement analysis
Fig. 35 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Homecare market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Diagnostic centers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Global GCC and UAE diabetes devices market: Regional movement analysis
Fig. 39 Global GCC and UAE diabetes devices market: Country outlook and key takeaways
Fig. 40 Global market share, by country
Fig. 41 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 UAE market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Oman market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Qatar market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Bahrain market estimates and forecast, 2018 - 2030 (USD Million)

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon